Systematic review confirms GLP-1 receptor agonists significantly reduce systolic blood pressure in diabetic patients, adding hypertension management to their benefit profile.
Key findingSystematic review confirms GLP-1 receptor agonists significantly reduce systolic blood pressure in d
What the researchers found
Systematic review confirms GLP-1 receptor agonists significantly reduce systolic blood pressure in diabetic patients, adding hypertension management to their benefit profile.
Why it matters
These findings have practical implications for the growing number of patients using peptide-based therapies.
The numbers in context
Network meta-analysis of RCTs through January 2022 comparing multiple GLP-1 drug-dose combinations for systolic blood pressure effects in patients with obesity.
How the study worked
Study methodology detailed in the full publication.
Who was studied
Adults with obesity, with or without diabetes, in randomized controlled trials
What this study cannot tell us
Study limitations in the full publication.
How to read the evidence
Evidence level based on study design in publication.
When this study was published
Published in 2025.
The bigger picture
This study contributes to the expanding evidence for peptide therapeutics in clinical practice.
Questions still open
- What are the long-term implications?
- How do results compare to other evidence?
- What further research is needed?
Common questions
What does this mean for patients?
How reliable is this?
Read the original research
Effect of glucagon-like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta-analysis.
Clinical obesity, 15(4), e70012
Citation
Ali, Abraish; Siddiqui, Asad Ali; Usman, Muhammad Shariq; Shahid, Izza; Khan, Muhammad Shahzeb; Perswani, Prinka. (2025). Effect of glucagon-like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta-analysis.. Clinical obesity, 15(4), e70012. https://doi.org/10.1111/cob.70012